Gastrointestinal Disorders

Latest News

Johnson & Johnson Submits sBLA for Approval of Guselkumab for Adults with Ulcerative Colitis / Image credit: ©Crystal Light/AdobeStock
Johnson & Johnson Submits sBLA for Approval of Guselkumab for Adults with Ulcerative Colitis

March 21st 2024

Submission based on results from the phase 3 QUASAR induction study, which showed statistically significant and clinically meaningful improvements in symptoms.

Women with IBD at Risk for Reduced Fertility: Daily Dose / image credit: ©New Africa/AdobeStock
Women with IBD at Risk for Reduced Fertility: Daily Dose

March 1st 2024

EoE in Children Treated with Dupilumab More Severe at Diagnosis, Study Finds image credit EoE graphic: ©Naeblys/stock.adobe.com
EoE in Children Treated with Dupilumab More Severe at Diagnosis, Study Finds

February 23rd 2024

Women with IBD at Risk for Reduced Fertility Even During Clinical Disease Remission, Study Suggests / image credit women's colon:  ©SciePro/stock.adobe.com
Women with IBD at Risk for Reduced Fertility Even During Clinical Disease Remission, Study Suggests

February 20th 2024

Budesonide Oral Suspension first approved for EoE / image credit Takeda logo: MichaelVi/stock.adobe.com
Takeda Announces Approval of First Oral Therapy for Eosinophilic Esophagitis

February 12th 2024

Latest CME Events & Activities

Show Me the Data: Bridging Clinical Gaps in Later Lines of Metastatic CRC… It’s Easy as VEGFR1, 2, 3!

April 17, 2024

View More

9th Annual School of Gastrointestinal Oncology® (SOGO®)

View More

Medical Crossfire®: Critical Questions on Diagnosis, Sequencing, and Selection of Systemic and Radioligand Therapy Options for Patients with GEP-NETs

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

Rapid Oncology Abstract Review®: Key Updates in Gastrointestinal Cancers from the ASCO Annual Meeting

View More

Medical Crossfire®: Bridging Precision Medicine Techniques and Emerging Treatments in Metastatic Colorectal Cancer

View More

Community Practice Connections™: 8th Annual School of Gastrointestinal Oncology®

View More

Burst CME: Incorporating the Latest Updates in IBS Treatment into Your Practice

View More

Advancing Care in Erosive Esophagitis: Towards a Path of Complete Healing

View More

Oncology Town Hall: Live Report from Barcelona for Advances in the Treatment of GI Cancers

View More

Cancer Summaries and Commentaries™: Clinical Updates in RCC from Chicago

View More

Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency

View More

2024 Miami International Symposium of Gastrointestinal Oncology (ISGIO)

October 11-12, 2024

Register Now!

6th Annual Precision Medicine Symposium: An Illustrated Tumor Board

October 18-19, 2024

Register Now!

Community Practice Connections™: 20th Annual Meeting of the International Society of Gastrointestinal Oncology®

View More

Working Group: Streamlining the Pathway from Diagnosis to Treatment in Inflammatory Bowel Disease

View More

Advances In™: The Evolving Role of VEGFR in the Treatment of Refractory mCRC

View More

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

Show Me the Data: Bridging Clinical Gaps in Later Lines of Metastatic CRC… It’s Easy as VEGFR1, 2, 3!

View More

The Next Wave in Biliary Tract Cancers: Leveraging Immunogenicity to Optimize Patient Outcomes in an Evolving Treatment Landscape

View More

Tissue Stewardship and the Evolving Role of Genomic Alterations in Providing Precision NSCLC Care

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News

© 2024 MJH Life Sciences

All rights reserved.